» Articles » PMID: 38313596

Unraveling Epigenetic Interplay Between Inflammation, Thrombosis, and Immune-Related Disorders Through a Network Meta-analysis

Overview
Journal TH Open
Publisher Thieme
Date 2024 Feb 5
PMID 38313596
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammation and thrombosis are two distinct yet interdependent physiological processes. The inflammation results in the activation of the coagulation system that directs the immune system and its activation, resulting in the initiation of the pathophysiology of thrombosis, a process termed immune-thrombosis. Still, the shared underlying molecular mechanism related to the immune system and coagulation has not yet been explored extensively. Inspired to answer this, we carried out a comprehensive gene expression meta-analysis using publicly available datasets of four diseases, including venous thrombosis, systemic lupus erythematosus, rheumatoid arthritis, and inflammatory bowel disease. A total of 609 differentially expressed genes (DEGs) shared by all four datasets were identified based on the combined effect size approach. The pathway enrichment analysis of the DEGs showed enrichment of various epigenetic pathways such as histone-modifying enzymes, posttranslational protein modification, chromatin organization, chromatin-modifying enzymes, HATs acetylate proteins. Network-based protein-protein interaction analysis showed epigenetic enzyme coding genes dominating among the top hub genes. The miRNA-interacting partner of the top 10 hub genes was determined. The predomination of epitranscriptomics regulation opens a layout for the meta-analysis of miRNA datasets of the same four diseases. We identified 30 DEmiRs shared by these diseases. There were 9 common DEmiRs selected from the list of miRNA-interacting partners of top 10 hub genes and shared significant DEmiRs from microRNAs dataset acquisition. These common DEmiRs were found to regulate genes involved in epigenetic modulation and indicate a promising epigenetic aspect that needs to be explored for future molecular studies in the context of immunothrombosis and inflammatory disease.

References
1.
Marot G, Foulley J, Mayer C, Jaffrezic F . Moderated effect size and P-value combinations for microarray meta-analyses. Bioinformatics. 2009; 25(20):2692-9. DOI: 10.1093/bioinformatics/btp444. View

2.
Mameli A, Barcellona D, Marongiu F . Rheumatoid arthritis and thrombosis. Clin Exp Rheumatol. 2009; 27(5):846-55. View

3.
Hooper W . The relationship between inflammation and the anticoagulant pathway: the emerging role of endothelial nitric oxide synthase (eNOS). Curr Pharm Des. 2004; 10(8):923-7. DOI: 10.2174/1381612043452857. View

4.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

5.
Kader H, Tchernev V, Satyaraj E, Lejnine S, Kotler G, Kingsmore S . Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. Am J Gastroenterol. 2005; 100(2):414-23. PMC: 1586185. DOI: 10.1111/j.1572-0241.2005.40819.x. View